Publications

2003
A. Tezel, A. Sens, and S. Mitragotri. 2003. “Description of Transdermal Transport of Hydrophilic Solutes during Low-Frequency Sonophoresis Based on a Modified Porous Pathway Model.” J. Pharm. Sci., 92, 1, Pp. 381-393.
J. Sundaram, B. Mellein, and S. Mitragotri. 2003. “An Experimental and Theoretical Analysis of Cell Membrane Permeabilization Induced by Low-Frequency Ultrasound.” Biophys. J., 84, Pp. 1-15.
J. Schramm and S. Mitragotri. 2003. “A Fundamental Investigation of Drug Delivery using Jet Injectors: Energetics of Jet Formation and Penetration.” Pharm. Res., 19, 11, Pp. 1673-1679.
S. Mitragotri. 2003. “Modeling Passive Skin Permeability to Hydrophilic and Hydrophobic Solutes based on Four Permeation Pathways.” J. Control. Rel., 86, 1, Pp. 69-92.
A. Tezel and S. Mitragotri. 2003. “On the Origin of Size-Dependent Tortuosity of Permeation of Hydrophilic Solutes across Stratum Corneum.” J. Control. Rel., 86, 1, Pp. 183-186.
J. Lahann, S. Mitragotri, S. Tran, H. Kaido, S. Sundaram, G. Somorjai, and R. Langer. 2003. “A Reversibly Switching Surface.” Science, 299, Pp. 371-774.
2002
T. Terahara, S. Mitragotri, J. Kost, and R. Langer. 2002. “Dependence of Low-Frequency Sonophoresis on Ultrasound Parameters: Distance of the Horn and Intensity.” Int. J. Pharm., 235, Pp. 35-42.
A. Tezel, A. Sanders, J. Tuscherer, and S. Mitragotri. 2002. “Frequency-dependence of Sonophoresis.” Pharm. Res., 18, 12, Pp. 1694-1700.
P. Karande and S. Mitragotri. 2002. “High Throughput Screening of Transdermal Enhancer Formulations.” Pharm. Res., 19, 5, Pp. 655-660.
A. Tezel, A. Sens, and S. Mitragotri. 2002. “Incorporation of Lipophilic Pathways into the Porous Pathway Model to Describe Transdermal Transport during Low-FrequencySonophoresis.” J. Control. Rel., 83, 1, Pp. 183-188.
Z. Shen and S. Mitragotri. 2002. “Intestinal Patches for Oral Drug Delivery.” Pharm. Res., 19, 4, Pp. 391-395.
A. Tezel, A. Sens, and S. Mitragotri. 2002. “Investigations of Role of Cavitation in Low-Frequency Sonophoresis using Acoustic Spectroscopy.” J. Pharm. Sci., 91, Pp. 444-453.
T. Terahara, S. Mitragotri, and R. Langer. 2002. “Porous Resins as a Cavitation Enhancer for Low Frequency Sonophoresis.” J. Pharm. Sci., 91, Pp. 753-759.
A. Tezel, A. Sens, J. Tuscherer, and S. Mitragotri. 2002. “Synergistic Effect of Surfactants and Low-Frequency Ultrasound on Skin Permeability.” J. Pharm. Sci., 91, 1, Pp. 91-100.
A. Tezel, A. Sens, and S. Mitragotri. 2002. “A Theoretical Analysis of Low-Frequency Sonophoresis: Dependence of Transdermal Transport Pathways on Frequency and Energy Density.” Pharm. Res., 19, 12, Pp. 1841-1846.
S. Mitragotri. 2002. “A Theoretical Analysis of Permeation of Small Hydrophobic Solutes across the Skin based on Scaled Particle Theory.” J. Pharm. Sci., 91, Pp. 754-757.
S. Mitragotri and J. Kost. 2002. “Ultrasound-Mediated Transdermal Drug Delivery.” In Modified-Release Drug Delivery Technology, edited by Rathbone, Hadgraft, and Roberts, Pp. 561-570.
2001
S. Mitragotri. 2001. “Effect of Bilayer Disrupting Agents on Skin Permeability to Low-Molecular Weight Hydrophobic Drugs.” Pharm. Res., 18, Pp. 1022-1028.
J. Kost, S. Mitragotri, and R. Langer. 2001. “Phonophoresis.” Topical Absorption of Dermatological Products, Pp. 335-351.
H. Tang, S. Mitragotri, D. Blankschtein, and R. Langer. 2001. “Theoretical Description of Transdermal Transport of Hydrophilic Permeants: Application to Low-Frequency Sonophoresis.” J. Pharm. Sci., 90, Pp. 543-566.

Pages